CSJZX
Price
$67.78
Change
-$0.62 (-0.91%)
Updated
Feb 21 closing price
Net Assets
7.18B
DREYX
Price
$43.26
Change
-$0.37 (-0.85%)
Updated
Feb 21 closing price
Net Assets
150.29M
Ad is loading...

CSJZX vs DREYX

Header iconCSJZX vs DREYX Comparison
Open Charts CSJZX vs DREYXBanner chart's image
Cohen & Steers Realty Shares Z
Price$67.78
Change-$0.62 (-0.91%)
VolumeN/A
Net Assets7.18B
Davis Real Estate Y
Price$43.26
Change-$0.37 (-0.85%)
VolumeN/A
Net Assets150.29M
CSJZX vs DREYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSJZX vs. DREYX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSJZX is a StrongSell and DREYX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CSJZX has more cash in the bank: 7.18B vs. DREYX (150M). CSJZX pays higher dividends than DREYX: CSJZX (3.03) vs DREYX (2.02). CSJZX was incepted earlier than DREYX: CSJZX (6 years) vs DREYX (28 years). CSJZX has a lower initial minimum investment than DREYX: CSJZX (0) vs DREYX (5000000). CSJZX annual gain was more profitable for investors over the last year : 13.21 vs. DREYX (8.56). CSJZX return over 5 years is better than : 9.33 vs. DREYX (2.18).
CSJZXDREYXCSJZX / DREYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years28 years-
Gain YTD2.8531.406203%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.18B150M4,784%
Annual Yield % from dividends3.032.02150%
Returns for 1 year13.218.56154%
Returns for 3 years1.31-8.02-16%
Returns for 5 years9.332.18427%
Returns for 10 yearsN/A37.83-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPRO13.06-0.33
-2.46%
Expro Group Holdings NV
ADSE14.78-0.39
-2.57%
Ads-Tec Energy PLC
MTSI120.65-3.36
-2.71%
MACOM Technology Solutions Holdings
ATOS0.80-0.04
-5.32%
Atossa Therapeutics
RKDA3.98-0.41
-9.41%
Arcadia Biosciences